It is less invasive and more cost-effective for patients and clinics, especially those who do not provide infusions. You can view the full study here.
Cagrilintide represents the breakthrough next-generation amylin agonist with weekly dosing, 10-12% monotherapy weight loss, and proven synergy with GLP-1 agonists when combined
Adding metformin or phentermine to your existing tirzepatide may also restart progress without switching entirely
Anxiety, psychosis, hostility, aggression, and suicidal or homicidal ideation have also been observed with CNS stimulants abuse and/or misuse
As the report observes, [t]he market share of Humira compared to its biosimilars is currently in a tenuous position, as manufacturers fiercely compete for preferred formulary positioning with pharmacy benefit managers (PBMs). MedBen currently offers the Humira biosimilar Idacio at a substantially reduced price, which will save clients nearly $3.3 million in 2024